Mass Screening of Human Papilloma Virus HPV: A New Cheaper Strategy

Cervical cancer is a major health issue for women globally, with around 530,000 new cases and 275,000 deaths each year. The global incidence of cervical cancer varies widely, ranging from 7.5 cases per 100,000 to 75.9 cases per 100,000 women. Also, cervical cancer represents the largest share of these HPV-related cancers. HPV screening is a proven method for preventing the development of cervical cancer. The 2020 guidelines from the American Cancer Society outline several screening strategies. More studies are needed to use the cheaper screening strategy to confirm its effective and cost-effective particularity making it valuable for early diagnosis and treatment of cervical cancer especially in economically limited areas.